Anxiolytic‐like Effects of the Positive GABAB Receptor Modulator GS39783 Correlate with Mice’s Individual Basal Anxiety and Stress Reactivity
Permanent link
https://hdl.handle.net/10037/26450Date
2022-02-16Type
Journal articleTidsskriftartikkel
Peer reviewed
Author
Bicakci, Ahmet Oguzhan; Sarkar, Mousumi; Chang, Yu-Hsin; Kahl, Evelyn; Ragazzi, Lorenzo; Moldes-Anaya, Angel; Fendt, MarkusAbstract
Positive gamma-aminobutyric acid type B (GABAB) receptor modulators such as GS39783
have showed anxiolytic-like effects in several studies while such effects were absent in other studies.
These conflicting findings led us hypothesize that the anxiolytic-like effects of such compounds
depend on the individual basal anxiety and/or the anxiogenic properties of the used tests. The
present study addresses this hypothesis by testing GS39783 effects on mice’s anxiety-like behavior
in a light–dark box. We found that GS39783 had no effects on a whole-group level. However, after
grouping the mice for their basal anxiety, GS39783 reduced anxiety-like behavior in the subgroup
with highest basal anxiety. Moreover, GS39783 effects correlated with individual basal anxiety. Next,
the anxiogenic properties of the light–dark box test were increased by prior stress exposure. Again,
GS39783 was not effective on a whole-group level. However, GS39783 had an anxiolytic-like effect in
the most stress-responsive subgroup. Moreover, GS39783 effects correlated with individual stress
responsiveness. Finally, we show that GS39783 brain levels were within a behaviorally relevant range.
Overall, our study demonstrates that GS39783 effects depend on individual basal anxiety and stress
responsiveness. This suggests that anxiety tests should generally be designed to capture individual
basal anxiety and/or stress responsiveness as well as individual compound effects.
Publisher
MDPICitation
Bicakci, Sarkar, Chang, Kahl, Ragazzi, Moldes-Anaya, Fendt. Anxiolytic‐like Effects of the Positive GABAB Receptor Modulator GS39783 Correlate with Mice’s Individual Basal Anxiety and Stress Reactivity. Pharmaceuticals. 2022;15(2)Metadata
Show full item recordCollections
Copyright 2022 The Author(s)